-
EP0165654
European procedure
Extract from the Register of European Patents
EP About this file: EP0165654
| EP0165654 - Purified interleukin 1 [Right-click to bookmark this link] | |||
| Former [1985/52] | Purified interleukin 1 and DNA coding for interleukin 1 and their preparation, vectors containing such DNA and their preparation and use in transforming hosts to permit expression of interleukin | ||
| [1992/26] | Status | Opposition rejected Status updated on 29.09.2000 Database last updated on 29.03.2025 | Most recent event Tooltip | 05.10.2005 | Change: Appeal number | Applicant(s) | For all designated states IMMUNEX CORPORATION 51 University Building Suite 600 Seattle Washington 98101 / US | [N/P] |
| Former [1985/52] | For all designated states IMMUNEX CORPORATION 51 University Building Suite 600 Seattle Washington 98101 / US | Inventor(s) | 01 /
Cerretti, Douglas P. 2415 West Bartona Seattle Washington 98199 / US | 02 /
Conlon III, Paul J. 4021 NE 75th Seattle Washington 98155 / US | 03 /
Cosman, David J. 310-12th Avenue East Seattle Washington 98102 / US | 04 /
Grabstein, Kenneth H. 5829 NE 75th Street, No. 443 Seattle Washington 98115 / US | 05 /
Hopp, Thomas P. 4842 - 51st SW Seattle Washington 98116 / US | 06 /
Kronheim, Shirley R. 11526-36th NE Seattle Washington 98125 / US | 07 /
Larsen, Alf D. 320 Summit Avenue East No. 15 Seattle Washington 98102 / US | 08 /
March, Carl J. 8133 Eighth SW Seattle Washington 98106 / US | 09 /
Price, Virginia L. 2617 Boyer Avenue East Seattle Washington 98102 / US | [1985/52] | Representative(s) | Sheard, Andrew Gregory, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | [N/P] |
| Former [1993/02] | Sheard, Andrew Gregory, et al Kilburn & Strode 30, John Street London WC1N 2DD / GB | ||
| Former [1986/45] | Sheard, Andrew Gregory Kilburn & Strode 30, John Street London WC1N 2DD / GB | ||
| Former [1986/41] | (deleted) | ||
| Former [1985/52] | Bizley, Richard Edward, et al BOULT, WADE & TENNANT 27 Furnival Street London EC4A 1PQ / GB | Application number, filing date | 85301752.3 | 13.03.1985 | [1985/52] | Priority number, date | US19840622201 | 19.06.1984 Original published format: US 622201 | US19840635006 | 27.07.1984 Original published format: US 635006 | US19840674555 | 26.11.1984 Original published format: US 674555 | US19840676533 | 30.11.1984 Original published format: US 676533 | US19840687646 | 31.12.1984 Original published format: US 687646 | [1985/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0165654 | Date: | 27.12.1985 | Language: | EN | [1985/52] | Type: | A3 Search report | No.: | EP0165654 | Date: | 04.05.1988 | Language: | EN | [1988/18] | Type: | B1 Patent specification | No.: | EP0165654 | Date: | 13.01.1993 | Language: | EN | [1993/02] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.03.1988 | Classification | IPC: | C07K13/00, C12N15/25, C12P21/02 | [1993/02] | CPC: |
C07K14/545 (EP);
A61P37/00 (EP);
A61P43/00 (EP);
C12N15/81 (EP)
|
| Former IPC [1985/52] | C12N15/00, C12P21/02, C07K13/00, C12N1/00 | Designated contracting states | AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE [1985/52] | Title | German: | Gereinigtes Interleukin-1 | [1992/26] | English: | Purified interleukin 1 | [1992/26] | French: | Interleukine-1 purifiée | [1992/26] |
| Former [1985/52] | Gereinigtes Interleukin-1 und für Interleukin-1 kodierende DNS und deren Herstellung, solche DNS enthaltende Vektoren und deren Herstellung und Verwendung zum Transformieren von Wirten, die die Expression von Interleukin-1 zulassen | ||
| Former [1985/52] | Purified interleukin 1 and DNA coding for interleukin 1 and their preparation, vectors containing such DNA and their preparation and use in transforming hosts to permit expression of interleukin | ||
| Former [1985/52] | Interleukine-1 purifiée et ADN codant pour l'interleukine-1 et leur préparation, vecteurs contenant cet ADN et leur préparation et utilisation dans la transformation des hôtes permetant l'expression d'interleukine-1 | Miscellaneous | EPB 1993/02: Teilanmeldung 91201769.6 eingereicht am 13/03/85 | EPB 1993/02: Divisional application 91201769.6 filed on 13/03/85 | EPB 1993/02: Demande divisionnaire 91201769.6 déposée le 13/03/85 | Examination procedure | 10.06.1988 | Examination requested [1988/32] | 19.12.1988 | Despatch of a communication from the examining division (Time limit: M04) | 28.04.1989 | Reply to a communication from the examining division | 27.11.1989 | Despatch of a communication from the examining division (Time limit: M10) | 08.10.1990 | Reply to a communication from the examining division | 13.02.1991 | Despatch of a communication from the examining division (Time limit: M04) | 24.06.1991 | Reply to a communication from the examining division | 30.01.1992 | Despatch of a communication from the examining division (Time limit: M02) | 19.03.1992 | Reply to a communication from the examining division | 12.05.1992 | Despatch of communication of intention to grant (Approval: Yes) | 17.07.1992 | Communication of intention to grant the patent | 25.09.1992 | Fee for grant paid | 25.09.1992 | Fee for publishing/printing paid | Divisional application(s) | EP91201769.6 / EP0456332 | Opposition(s) | Opponent(s) | 01
13.10.1993
15.11.1993
ADMISSIBLE New England Medical Center Hospitals, Inc. 750 Washington Street USA- Boston MA 02111 / US Opponent's representative Perry, Robert Edward Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB | [N/P] |
| Former [1993/49] | |||
| Opponent(s) | 01
13.10.1993
15.11.1993
ADMISSIBLE New England Medical Center Hospitals, Inc. 171 Harrison Avenue USA- Boston MA 02111 / US Opponent's representative Perry, Robert Edward GILL JENNINGS & EVERY Broadgate House 7 Eldon Street London EC2M 7LH / GB | 19.11.1993 | Invitation to proprietor to file observations on the notice of opposition | 27.05.1994 | Reply of patent proprietor to notice(s) of opposition | 05.04.1995 | Date of oral proceedings | 06.07.1995 | Despatch of minutes of oral proceedings | 06.07.1995 | Date of despatch of rejection of opposition | 24.09.2000 | Legal effect of rejection of opposition [2000/46] | Appeal following opposition | 07.09.1995 | Appeal received No. T0767/95 | 07.11.1995 | Statement of grounds filed | 05.09.2000 | Result of appeal procedure: appeal of the opponent was rejected | Fees paid | Renewal fee | 09.03.1987 | Renewal fee patent year 03 | 07.03.1988 | Renewal fee patent year 04 | 13.03.1989 | Renewal fee patent year 05 | 15.03.1990 | Renewal fee patent year 06 | 17.12.1990 | Renewal fee patent year 07 | 13.03.1992 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]EP0092163 (SLOAN KETTERING INST CANCER [US]); | [E]EP0161901 (NEW ENGLAND MEDICAL CENTER INC [US], et al); | [E]EP0187991 (OTSUKA PHARMA CO LTD [JP]) | [XD] - THE JOURNAL OF IMMUNOLOGY, vol. 122, no. 5, May 1979, pages 2112-2118, The Williams & Wilkins CO.; ATSUSHI TOGAWA et al.: "Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF" | [XP] - LYMPHOKINE RESEARCH, vol. 3, no. 4, Summer 1984, page 285, Mary Ann Liebert, Inc. Publishers, New York, US; P.E. AURON et al.: "Molecular cloning of human interleukin-1 (IL-1) cDNA" | Examination | - Rev. Inf. Diseases 6 (Jan-Feb 1984) 51-95 | - Fed. Proc. 42 (1983) 2639-2645 | - J. Exp. Med. 160 (Sept. 1984) 772-787 | - Proc. Nat. Acad. Sci. USA 81 (dec. 1984) 7907-7911 | - Proc. Nat. Acad. Sci. USA 84 (1987) 4572-4576 | - Immunol. Today 3 (1982) 89-94 | - Proc. Nat. Acad. Sci. USA 74 (1977) 4624-7 | - Nature 309 (may 1984) 56-60 |